These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9444427)

  • 1. Immune cell biochemical abnormalities in systemic lupus erythematosus.
    Liossis SN; Vassilopoulos D; Kovacs B; Tsokos GC
    Clin Exp Rheumatol; 1997; 15(6):677-84. PubMed ID: 9444427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell signaling abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Tsokos GC
    Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging concepts in the molecular pathogenesis of systemic lupus erythematosus.
    Nambiar MP; Juang YT; Tsokos GC
    Arch Immunol Ther Exp (Warsz); 2002; 50(1):35-45. PubMed ID: 11916307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular aberrations in human systemic lupus erythematosus.
    Tsokos GC; Kammer GM
    Mol Med Today; 2000 Nov; 6(11):418-24. PubMed ID: 11074367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cells and cytokines in systemic lupus erythematosus: an update.
    Kyttaris VC; Juang YT; Tsokos GC
    Curr Opin Rheumatol; 2005 Sep; 17(5):518-22. PubMed ID: 16093827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
    Fujii Y; Fujii K; Tanaka Y
    Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of systemic lupus erythematosus.
    Francis L; Perl A
    Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell receptor signaling in human systemic lupus erythematosus.
    Pugh-Bernard AE; Cambier JC
    Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocytes in systemic lupus erythematosus: an update.
    Kyttaris VC; Tsokos GC
    Curr Opin Rheumatol; 2004 Sep; 16(5):548-52. PubMed ID: 15314492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
    Wong HK; Kammer GM; Dennis G; Tsokos GC
    J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes, cytokines, inflammation, and immune trafficking.
    Tsokos GC
    Curr Opin Rheumatol; 1994 Sep; 6(5):461-7. PubMed ID: 7993702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus.
    Blossom S; Chu EB; Weigle WO; Gilbert KM
    J Immunol; 1997 Nov; 159(9):4580-6. PubMed ID: 9379059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets.
    Shao WH; Cohen PL
    Expert Rev Clin Immunol; 2014 May; 10(5):573-82. PubMed ID: 24678775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.
    Liossis SN; Kovacs B; Dennis G; Kammer GM; Tsokos GC
    J Clin Invest; 1996 Dec; 98(11):2549-57. PubMed ID: 8958217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
    Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus conundrums.
    Wardle EN
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):731-6. PubMed ID: 19736466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal early TCR/CD3-mediated signaling events of a snRNP-autoreactive lupus T cell clone.
    Liossis SN; Hoffman RW; Tsokos GC
    Clin Immunol Immunopathol; 1998 Sep; 88(3):305-10. PubMed ID: 9743618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR zeta-chain abnormalities in human systemic lupus erythematosus.
    Nambiar MP; Krishnan S; Warke VG; Tsokos GC
    Methods Mol Med; 2004; 102():49-72. PubMed ID: 15286380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered signaling triggered by ligation of the TCR/CD3 receptor in T lymphocytes from patients with systemic lupus erythematosus: the road from anergy to autoimmunity.
    Blasini AM; Rodríguez MA
    Int Rev Immunol; 2004; 23(3-4):265-72. PubMed ID: 15204088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.